Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle

Biology of Reproduction

Volumn 89, Issue 5, 2013, Pages

  Rosewell, Katherine L ^a   Li, Feixue ^b   Puttabyatappa, Muraly ^a   Akin, James W ^c   Brännström, Mats ^d   Curry Jr , Thomas E ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b HANGZHOU NORMAL UNIVERSITY   (China)

^c Bluegrass Fertility Center   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Follicle; Granulosa cell; Human; Ovary; Ovulation; Protease inhibitor; Theca cell

Indexed keywords

MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; ARTICLE; CELL SEPARATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEAL CELL; MENSTRUAL CYCLE; OVARY FOLLICLE; OVULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE STUDY; THECA CELL;

FOLLICLE; GRANULOSA CELL; HUMAN; OVARY; OVULATION; PROTEASE INHIBITOR; THECA CELL;

ADULT; CELLS, CULTURED; CHORIONIC GONADOTROPIN; FEMALE; GENE EXPRESSION; HUMANS; LUTEAL CELLS; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARY; OVULATION; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84901052601     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.106989     Document Type: Article

References (51)

1. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477:267-283.
2. Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 2001; 494:192-195.
3. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, Docherty AJ, Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 2000; 473:275-279.
4. Russell DL, Doyle KM, Ochsner S, Sandy JD, Richards JS. Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem 2003; 278: 42330-42339.
5. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435:39-44.
6. Kashiwagi M, Tortorella M, Nagase H, Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAMTS5). J Biol Chem 2001; 276:12501-12504.
7. Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta 2012; 1824:146-156.
8. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 1991; 97:679-685.
9. Corcoran ML, Kleiner DE Jr, Stetler-Stevenson WG. Regulation of matrix metalloproteinases during extracellular matrix turnover. Adv Exp Med Biol 1995; 385:151-159.
10. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growthpromoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994; 107(pt 9):2373-2379.
11. Taube ME, Liu XW, Fridman R, Kim HR. TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein. Oncogene 2006; 25:3041-3048.
12. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R. Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 1999; 211:238-254.
13. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157:351-358.
14. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990; 248:1408-1410.
15. Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005; 115:849-860.
16. Kang KH, Park SY, Rho SB, Lee JH. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Cardiovasc Res 2008; 79:150-160.
17. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9:407-415.
18. Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi KK, Davis GE. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 2006; 175:179-191.
19. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 1999; 79:1347-1355.
20. Ahonen M, Baker AH, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998; 58:2310-2315.
21. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, Kahari VM. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003; 22: 2121-2134.
22. Li G, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 1999; 59: 6267-6275.
23. Liu XW, Bernardo MM, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 2003; 278: 40364-40372.
24. Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res 2005; 65:898-906.
25. Berisha B, Steffl M, Welter H, Kliem H, Meyer HH, Schams D, Amselgruber W. Effect of the luteinising hormone surge on regulation of vascular endothelial growth factor and extracellular matrix-degrading proteinases and their inhibitors in bovine follicles. Reprod Fertil Dev 2008; 20:258-268.
26. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003; 24:428-465.
27. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000; 275:31226-31232.
28. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992; 267:17321-17326.
29. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 2010; 1803:55-71.
30. Simpson KS, Byers MJ, Curry TE Jr. Spatiotemporal mRNA expression of the tissue inhibitors of metalloproteinases (TIMPs) in the ovary throughout the rat estrous cycle. Endocrinology 2000; 142:2058-2069.
31. Curry TE Jr, Song L, Wheeler SE. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation and early luteal formation in the rat. Biol Reprod 2001; 65:855-865.
32. Lind AK, Dahm-Kahler P, Weijdegard B, Sundfeldt K, Brannstrom M. Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1. Mol Hum Reprod 2006; 12:725-736.
33. Andersen AG, Als-Nielsen B, Hornnes PJ, Franch AL. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod 1995; 10:3202-3205.
34. Lind AK. Human ovulation: studies on collagens, gelatinases and tissue inhibitors of metalloproteinases. Gothenburg, Sweden: The Sahlgrenska Academy, University of Gothenburg; 2006. Thesis.
35. Augustin HG. Vascular morhogenesis in the ovary. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:867-882.
36. Yang TT, Hawkes SP. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10676-10680.
37. Zorn JR, Roger M, Savale M, Grenier J. Steroid hormone levels in peritoneal fluid during the periovulatory period. Fertil Steril 1982; 38: 162-165.
38. Li F, Curry TE Jr. Regulation and function of tissue inhibitor of metalloproteinase (TIMP) 1 and TIMP3 in periovulatory rat granulosa cells. Endocrinology 2009; 150:3903-3912.
39. Inderdeo DS, Edwards DR, Han VKM, Khokha R. Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. Biol Reprod 1996; 55:498-508.
40. Hagglund AC, Ny A, Leonardsson G, Ny T. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology 1999; 140:4351-4358.
41. Oksjoki SM, Sallinen S, Vuorio E, Anttila L. Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary. Mol Hum Reprod 1999; 5:803-808.
42. Li Q, Bakke LJ, Pursley JR, Smith GW. Localization and temporal regulation of tissue inhibitors of metalloproteinases 3 and 4 in bovine preovulatory follicles. Reproduction 2004; 128:555-564.
43. Simpson KS, Byers MJ, Curry TE Jr. Spatiotemporal messenger ribonucleic acid expression of ovarian tissue inhibitors of metalloproteinases throughout the rat estrous cycle. Endocrinology 2001; 142: 2058-2069.
44. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, Khokha R. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 2006; 176:721-725.
45. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R. Abnormal TNF activity in Timp3-/-mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004; 36:969-977.
46. Ripley D, Tunuguntla R, Susi L, Chegini N. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and 4 in normal ovary and ovarian carcinoma. Int J Gynecol Cancer 2006; 16:1794-1800.
47. Shores EM, Hunter MG. Production of tissue inhibitors of metalloproteinases (TIMPs) by pig ovarian cells in vivo and the effect of TIMP-1 on steroidogenesis in vitro. J Reprod Fertil 2000; 120:73-81.
48. Riley SC, Gibson AH, Leask R, Mauchline DJ, Pedersen HG, Watson ED. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries. Reproduction 2001; 121:553-560.
49. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 2008; 9:246.
50. Troeberg L, Fushimi K, Khokha R, Emonard H, Ghosh P, Nagase H. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 2008; 22:3515-3524.
51. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 2001; 32:567-575.